AIDS INFORMATION NEWSLETTER Michael Howe, MSLS, Editor AIDS Information Center VA Medical Center, San Francisco (415) 221-4810 ext 3305 July 14, 1995 Opportunistic Infections (Part IV) Bibliography of OI Review Articles - Section C [Editor's Note: This is the third of three parts of a bibliography that includes references for review articles for opportunistic infections.] VI. INFECTIONS - VIRAL A. DRUGS 1. Drugs for Non-HIV Viral Infections. The Medical Letter on Drugs and Therapeutics. 1994;36(Issue 919):27-32. 2. Drugs for Viral Infections. The Medical Letter on Drugs and Therapeutics. 1992; 34(Issue 867):31-6. B. CYTOMEGALOVIRUS 1. Anand R. Font RL. Fish RH. et al. Pathology of Cytomegalovirus Retinitis Treated with Sustained Release Intravitreal Ganciclovir. Ophthalmology. 1993 July;100(7):1032-9. 2. Buckner FS. Pomeroy C. Cytomegalovirus Disease of the Gastrointestinal Tract in Patients without AIDS. Clinical Infectious Diseases. 1993;17:644-56. 3. Drew WL. Cytomegalovirus Infection in Patients with AIDS. Clinical Infectious Diseases. 1992 Feb;14:608-15. 4. Flores-Aguilar M. Kuppermann BD. Quiceno JI. et al. Pathophysiology and Treatment of Clinically Resistant Cytomegalovirus Retinitis. Ophthalmology. 1993 July;100(7):1022-31. 5. Foscarnet. Medical Letter on Drugs & Therapeutics. 1992;34(Issue 861):3-4. 6. Ganciclovir. Medical Letter on Drugs & Therapeutics. 1989 Aug;31(Issue 799):79-80. 7. Heinemann MH. Characteristics of Cytomegalovirus Retinitis in Patients with Acquired Immunodeficiency Syndrome. American Journal of Medicine. 1992 Feb 14;92(Suppl 2A):12S-15S. 8. Jacobson MA. Current Management of Cytomegalovirus Disease in Patients with AIDS. AIDS Research and Human Retroviruses. 1994;10(8):917-923. 9. Jones AC. Freedman PD. Phelan JA. et al. Cytomegalovirus Infections of the Oral Cavity: A Report of Six Cases and Review of the Literature. Oral Surgery, Oral Medicine, Oral Pathology. 1993 Jan;75(1):76-85. 10. Markham A. and Faulds D. Ganciclovir: An Update of its Therapeutic Use in Cytomegalovirus Infection. Drugs. 1994;48(3):455-484. 11. Polis MA. Foscarnet and Ganciclovir in the Treatment of Cytomegalovirus Retinitis. Journal of Acquired Immune Deficiency Syndromes. 1992;5(Suppl 1):S3-S10. 12. Smith MA. Brennessel DJ. Cytomegalovirus. Infectious Disease Clinics of North America. 1994;8(2):427-438. 13. Wagstaff AJ. Bryson HM. Foscarnet: A Reappraisal of its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Use in Immunocompromised Patients with Viral Infections. Drugs. 1994;48(2):199-226. C. HERPES SIMPLEX/ZOSTER 1. Birch CJ. Tyssen DP. Tachedjian G. et al. Clinical Effects and In Vitro Studies of Trifluorothymidine Combined with Interferon-alpha for Treatment of Drug- Resistant and -Sensitive Herpes Simplex Virus Infections. Journal of Infectious Diseases. 1992;166:108-12. 2. Buchbinder SP. Katz MH. Hessol NA. Herpes Zoster and Human Immunodeficiency Virus Infection. Journal of Infectious Diseases. 1992;166:1153-6. 3. Drew WL. Buhles W. Erlich KS. Management of Herpes Virus Infections (CMV, HSV, VZV). In: Sande MA. Volberding PA., eds. The Medical Management of AIDS. 3rd ed. Philadelphia: W.B. Saunders, 1992:359-82. 4. Famciclovir for Herpes Zoster. The Medical Letter on Drugs and Therapeutics. 1994;36(Issue 934):97-98. 5. Hardy WD. Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus Infection in Patients with Acquired Immunodeficiency Syndrome: Preliminary Results of a Controlled, Randomized, Regimen-Comparative Trial. American Journal of Medicine. 1992 Feb 14;92(Suppl 2A):30S-35S. 6. Jacobson MA. Foscarnet Therapy for AIDS-Related Opportunistic Herpesvirus Infections. In: Volberding P. Jacobson MA., Eds. AIDS Clinical Review 1992. New York: Marcel Dekker, Inc., 1992:173-89. 7. Kost RG. Hill EL. Tigges M. et al. Brief Report: Recurrent Acyclovir-Resistant Genital Herpes in an Immunocompetent Patient. New England Journal of Medicine. 1993;329(24):1777-82. 8. Safrin S. Treatment of Acyclovir-Resistant HSV and VZV Infections. The AIDS Reader. 1994;4(2):59-65. 9. Safrin S. Ashley R. Houlihan C. et al. Clinical and Serologic Features of Herpes Simplex Virus Infection in Patients with AIDS. AIDS. 1991:5:1107-10. 10. Safrin S. Kemmerly S. Plotkin B. et al. Foscarnet- Resistant Herpes Simplex Infection in Patients with AIDS. Journal of Infectious Diseases. 1994;169:193-6. 11. Whitley RJ. Gnann JW. Acyclovir: A Decade Later. New England Journal of Medicine. 1992 Sept 10;327(11):782- 9. D. PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1. Hair LS. Nuovo G. Powers JM. et al. Progressive Multifocal Leukoencephalopathy in Patients with Human Immunodeficiency Virus. Human Pathology. 1992 Jun;23(6):663-7. 2. Karahalios D. Breit R. Dal Canto MC. et al. Progressive Multifocal Leukoencephalopathy in Patients with HIV Infection: Lack of Impact of Early Diagnosis by Stereotactic Brain Biopsy. Journal of Acquired Immune Deficiency Syndromes. 1992;5(10):1030-8. 3. Weber T. Turner RW. Frye S. et al. Specific Diagnosis of Progressive Multifocal Leukoencephalopathy by Polymerase Chain Reaction. Journal of Infectious Diseases. 1994;169:1138-41. 4. Whiteman ML. Post MJ. Berger JR. et al. Progressive Multifocal Leukoencephalopathy in 47 HIV-Seropositve Patients: Neuroimaging with Clinical and Pathologic Correlation. Radiology. 1993 Apr;187(1):233-40. VII. INFECTIONS - OTHER A. SYPHILIS/NEUROSYPHILIS 1. Deschenes J. Seamone CD. Baines MG. Acquired Ocular Syphilis: Diagnosis and Treatment. Annals of Ophthalmology. 1992;24(4):134-8. 2. Dowell ME. Ross PG. Musher DM. et al. Response of Latent Syphilis or Neurosyphilis to Ceftriaxone Therapy in Persons Infected With Human Immunodeficiency Virus. American Journal of Medicine. 1992 Nov;93:481-8. 3. Gordon SM. Eaton ME. George R. et al. The Response of Symptomatic Neurosyphilis to High-Dose Intravenous Penicillin G in Patients with Human Immunodeficiency Virus Infection. New England Journal of Medicine. 1994;331(22):1469-1473. 4. Hook EW. Marra CM. Acquired Syphilis in Adults. New England Journal of Medicine. 1992 Apr 16;326(16):1060- 9. 5. Hutchinson CM. Hook EW. Shepherd M. et al. Altered Clinical Presentation of Early Syphilis in Patients with Human Immunodeficiency Virus Infection. Annals of Internal Medicine. 1994;121:94-99. 6. Katz DA. Berger JR. Duncan RC. Neurosyphilis: A Comparative Study of the Effects of Infection with Human Immunodeficiency Virus. Archives of Neurology. 1993;50:243-9. 7. Matlow AG. Rachlis AR. Syphilis Serology in Human Immunodeficiency Virus-Infected Patients With Symptomatic Neurosyphilis: Case Report and Review. Reviews of Infectious Diseases. 1990 Jul-Aug;12(4):703-7. 8. Musher DM. Syphilis, Neurosyphilis, Penicillin, and AIDS. Journal of Infectious Diseases. 1991;163:1201-6. 9. Tomberlin MG. Holtom PD. Owens JL. et al. Evaluation of Neurosyphilis in Human Immunodeficiency Virus-Infected Individuals. Clinical Infectious Diseases. 1994;18:288- 294. 10. Tramont EC. Syphilis in HIV-Infected Persons. In: Volberding P. Jacobson MA. Eds., AIDS Clinical Review 1993/1994. New York: Marcel Dekker, Inc., 1994:61-72. VIII. MALIGNANCIES A. REVIEW ARTICLE 1. Levine AM. AIDS-Related Malignancies: The Emerging Epidemic. Journal of the National Cancer Institute. 1993 Sept;85(17):1382-97. B. CERVICAL CANCER 1. Braun L. Role of Human Immunodeficiency Virus Infection in the Pathogenesis of Human Papillomavirus-Associated Cervical Neoplasia. American Journal of Pathology. 1994;144(2):209-214. 2. Centers for Disease Control and Prevention. Risk for Cervical Disease in HIV-Infected Women - New York City. MMWR. 1990 Nov;39(47):846-9. 3. Hankins CA. Lamont JA. Handley MA. Cervicovaginal Screening in Women with HIV Infection: A Need for Increased Vigilance? Canadian Medical Association Journal. 1994 Mar;150(5):681-6. 4. Laga M. Icenogle JP. Marsella R. et al. Genital Papillomavirus Infection and Cervical Dysplasia-- Opportunistic Complications of HIV Infection. International Journal of Cancer. 1992;50:45-8. 5. Maiman M. Fruchter RG. Guy L. et al. Human Immunodeficiency Virus Infection and Invasive Cervical Carcinoma. Cancer. 1993 Jan;71(2):402-6. 6. Mandelblatt JS. Fahs M. Garibaldi K. et al. Association Between HIV Infection and Cervical Neoplasia: Implications for Clinical Care of Women at Risk for Both Conditions. AIDS. 1992;6(2):173-8. 7. Schafer A. Friedmann W. Mielke M. et al. The Increased Frequency of Cervical Dysplasis-Neoplasia in Women Infected with the Human Immunodeficiency Virus is Related to the Degree of Immunosuppression. American Journal of Obstetrics and Gynecology. 1991 Feb;164(2):593-9. 8. Vermund SH. Kelley KF. Klein RS. et al. High Risk of Human Papillomavirus Infection and Cervical Squamous Intraepithelial Lesions Among Women with Symptomatic Human Immunodeficiency Virus Infection. American Journal of Obstetrics and Gynecology. 1991 Aug;165(2):392-400. C. KAPOSI'S SARCOMA 1. Bogner JR. Kronawitter U. Rolinski B. et al. Liposomal Doxorubicin in the Treatment of Advanced AIDS-Related Kaposi Sarcoma. Journal of Acquired Immune Deficiency Syndromes. 1994;7:463-468. 2. Chang Y. Ceasarman E. Pessin MS. Identification of Herpesvirus-Like DNA Sequences in AIDS-Associated Kaposi's Sarcoma. Science. 1994;266:1865-1869. 3. De Wit R. AIDS-Associated Kaposi's Sarcoma and the Mechanism of Interferon Alpha's Activity; A Riddle within a Puzzle. Journal of Internal Medicine. 1992;231:321-5. 4. Fischl MA. Krown SE. O'Boyle KP. et al. Weekly Doxorubicin in the Treatment of Patients with AIDS- Related Kaposi's Sarcoma. Journal of Acquired Immune Deficiency Syndromes. 1993;6(3):259-64. 5. Hengge UR. Brockmeyer NH. Liposomal Doxorubicin in AIDS- related Kaposi's sarcoma. Lancet. 1993 Aug;342(8869):497. 6. Kahn JO. Northfelt DW. Miles SA. AIDS-Associated Kaposi's Sarcoma. In: Volberding PA. Jacobson MA. eds. AIDS Clinical Review 1992. New York: Marcel Dekker Inc, 1992:261-80. 7. Krown SE. Myskowski PL. Paredes J. Kaposi's Sarcoma. Medical Clinics of North America. 1992 Jan;76(1):235- 52. 8. Lilenbaum RC and Ratner L. Systemic Treatment of Kaposi's Sarcoma: Current Status and Future Directions. AIDS. 1994;8:141-151. 9. Peasant CA. Scolaro M. Kennedy P. et al. Liposomal Daunorubicin Treatment of HIV-Associated Kaposi's Sarcoma. Lancet. 1993 May;341(8855):1242-3. 10. Tappero JW. Conant MA. Wolfe SF. et al. Kaposi's Sarcoma: Epidemiology, Pathogenesis, Histology, Clinical Spectrum, Staging Criteria and Therapy. Journal of the American Academy of Dermatology. 1993 Mar;28(3):371-95. D. NON-HODGKIN'S LYMPHOMA and HODGKIN'S DISEASE 1. Armitage JO. Treatment of Non-Hodgkin's Lymphoma. New England Journal of Medicine. 1993 Apr;328(14):1023-30. 2. Beral V. Peterman T. Berkelman R. et al. AIDS-Associated Non-Hodgkin Lymphoma. Lancet. 1991 Apr 6;337(8745):805- 9. 3. Centers for Disease Control and Prevention. Opportunistic Non-Hodgkin's Lymphomas Among Severely Immunocompromised HIV-Infected Patients Surviving for Prolonged Periods on Antiretroviral Therapy--United States. MMWR. 1991 Aug 30;40(34):591, 597-600. 4. Dina TS. Primary Central Nervous Lymphoma Versus Toxoplasmosis in AIDS. Radiology. 1991 Jun;179:823-8. 5. Errante D. Tirelli U. Gastaldi R. et al. Combined Antineoplastic and Antiretroviral Therapy for Patients with Hodgkin's Disease and Human Immunodeficiency Virus Infection. Cancer. 1994:73(2):437-444. 6. Gisselbrecht C. Oksenhendler E. Tirelli U. et al. Human Immunodeficiency Virus-Related Lymphoma Treatment with Intensive Combination Chemotherapy. American Journal of Medicine. 1993 Aug;95:188-96. 7. Kaplan LD. HIV-Associated Lymphoma. In: AIDS Clinical Review 1993/1994. New York:Marcel Dekker, Inc., 1994:145- 66. 8. Levine AM. AIDS-Associated Malignant Lymphoma. Medical Clinics of North America. 1992 Jan;76(1):253-68. 9. Ling SM. Roach M. Larson DA. et al. Radiotherapy of Primary Central Nervous System Lymphoma in Patients with and without Human Immunodeficiency Virus. Cancer. 1994;73(10):2570-82. 10. Newcom SR. Ward M. Napoli VM. et al. Treatment of Human Immunodeficiency Virus-Associated Hodgkin Disease. Cancer. 1993 May;71(10):3138-45. 11. Rubio R. Hodgkin's Disease Associated with Human Immunodeficiency Virus Infection: A Clinical Study of 46 Cases. Cancer. 1994;73(9):2400-07. E. SQUAMOUS CELL CARCINOMA 1. Chadha M. Rosenblatt EA. Malamud S. et al. Squamous-cell Carninoma of the Anus in HIV-Positive Patients. Diseases of Colon & Rectum. 1994 Sep;37(9):861-5. 2. Hald J. Larsen PL. Nasopharyngeal Carcinoma in an HIV- Positive Patient Causing Severe Morbidity and Early Death. Journal of Laryngology and Otology. 1993 Feb;107;149-50. 3. Lorenz HP. Wilson W. Leigh B. et al. Squamous Cell Carcinoma of the Anus and HIV Infection. Diseases of the Colon and Rectum. 1991 Apr;34(4):336-8. 4. Roland JT. Rothstein SG. Mittal KR. et al. Squmous Cell Carcinoma in HIV-Positive Patients Under Age 45. Laryngoscope. 1993 May;103:509-11. 5. Smith DE. Shah KH. Rao AR. et al. Cancer of the Anal Canal: Treatment with Chemotherapy and Low-Dose Radiation Therapy. Radiology. 1994 May;191(2):569-72. 6. Surawicz CM. Kirby P. Critchlow C. et al. Anal Dysplasia in Homosexual Men: Role of Anoscopy and Biopsy. Gastroenterology. 1993;105(3):658-66.